Komal L Jhaveri

Biosketch / Results /

Komal L Jhaveri, M.D.

Assistant Professor;
Department of Medicine (Medicine)

Clinical Addresses

160 East 34th Street
New York, NY 10016
Hours: Mon. 9 - 5; Wed. 9 - 5
Handicap Access: yes
Phone: 212-731-5835
Fax: 212-731-5342

« Back to Results

Medical Specialties

Medical Oncology

Medical Expertise

Breast Cancer, Breast Oncology

I am a board-certified medical oncologist who specializes in the treatment of breast cancer. I am part of a team of expert, compassionate physicians who work together to provide multidisciplinary care to patients with breast cancer. Through my research I focus on developing more-effective and less-toxic treatment strategies for women with this disease. My particular interest is in developing phase I/II clinical trials using novel targeted therapies for both early stage and metastatic breast cancer (including inflammatory breast cancer and patients with brain metastases) and using Imaging as a biomarker for either drug development or response assessment.

Languages

Spanish

Insurance

AETNA HMO, AETNA INDEMNITY, AETNA MEDICARE, AETNA POS, AETNA PPO/EPO, AFFINITY, CIGNA EPO/POS, Cigna PPO, EBCBS EPO, EBCBS HLTHY NY, EBCBS HMO, EBCBS INDEMNITY, EBCBS MEDIBLUE, EBCBS PATHWAYS / PATHWAYS ENHANCED, EBCBS POS, EBCBS PPO, ELDERPLAN, FIDELIS CHLD HLTH, FIDELIS EXCHANGE, FIDELIS FAM HLTH, FIDELIS MEDICARE, Fidelis Medicaid, GHI CBP, HEALTHPLUS CHLD HLTH (AMERIGROUP), HEALTHPLUS FAM HLTH (AMERIGROUP), HEALTHPLUS MEDICAID (AMERIGROUP), HEALTHREPUBLIC, HIP ACCESS I, HIP ACCESS II, HIP CHLD HLTH, HIP EPO/PPO, HIP FAM HLTH, HIP HMO, HIP MEDICAID, HIP MEDICARE, HIP POS, LOCAL 1199 PPO, MAGNACARE PPO, METROPLUS CHLD HLTH, METROPLUS EXCHANGE PLANS, METROPLUS FAM HLTH, MULTIPLAN/PHCS PPO, Medicare, MetroPlus Medicaid, NYS EMPIRE PLAN, OSCAR, OXFORD EXCHANGE, OXFORD FREEDOM, Oxford Liberty, Oxford Medicare Tricare, UHC COMMUNITY & STATE PLAN, UHC EPO, UHC HMO, UHC MEDICARE, UHC POS, UHC PPO, UHC TOP TIER, UNITED EXCHANGE- COMPASS

Insurance Disclaimer: Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have changed.

« Back to Results

Board Certification

2009 — Ab Internal Medicine - Internal Medicine
— Ab Internal Medicine (Medical Oncology)

Education

1995-2001 — KJ Somaiya Medical College & Research Center, Medical Education
2001-2003 — Radiation Medicine Center - University of Mumbai (Nuclear Medicine), Residency Training
2006-2009 — St. Luke's-Roosevelt Hospital Ctr. (Internal Medicine), Residency Training
2009-2012 — Memorial Sloan-Kettering Cancer Center (Hematology/Oncology), Clinical Fellowships

« Back to Results

Research Interests

I am currently leading two clinical trials in patients with HER2 positive metastatic breast cancer. One of these trials will be open to patient accrual in October 2013 and the other in January 2014.

« Back to Results

All data from NYU Health Sciences Library Faculty Bibliography — -

Contact:
http://hsl.med.nyu.edu/faculty-bibliography-search

Genome-Based Risk Prediction for Early Stage Breast Cancer
Adaniel, Christina; Jhaveri, Komal; Heguy, Adriana; Esteva, Francisco J
2014 Sep;:4757-4757, Oncologist
— id: 1180912, year: 2014, vol: , page: 4757, stat: Journal Article,

Pertuzumab in the Treatment of HER2+ Breast Cancer
Jhaveri, Komal; Esteva, Francisco J
2014 Apr;12(4):591-598, Journal of the National Comprehensive Cancer Network : JNCCN
— id: 979362, year: 2014, vol: 12, page: 591, stat: Journal Article,

Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions
Jhaveri, Komal; Ochiana, Stefan O; Dunphy, Mark Ps; Gerecitano, John F; Corben, Adriana D; Peter, Radu I; Janjigian, Yelena Y; Gomes-Dagama, Erica M; Koren, John 3rd; Modi, Shanu; Chiosis, Gabriela
2014 May;23(5):611-628, Expert opinion on investigational drugs
— id: 938302, year: 2014, vol: 23, page: 611, stat: Journal Article,

Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer
Singh, JC; Novik, Y; Stein, S; Volm, M; Meyers, M; Smith, J; Omene, C; Speyer, J; Schneider, R; Jhaveri, K; Formenti, S; Kyriakou, V; Joseph, B; Goldberg, JD; Li, X; Adams, S; Tiersten, A
2014 ;16(2):- R32, Breast cancer research
— id: 1059672, year: 2014, vol: 16, page: , stat: Journal Article,

Hepatic arterial infusion and systemic chemotherapy for breast cancer liver metastases
Ang, Celina; Jhaveri, Komal; Patel, Dina; Gewirtz, Alexandra; Seidman, Andrew; Kemeny, Nancy
2013 Jan-Feb;19(1):96-99, Breast journal
— id: 551492, year: 2013, vol: 19, page: 96, stat: Journal Article,

Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer
Domchek, Susan M; Jhaveri, Komal; Patil, Sujata; Stopfer, Jill E; Hudis, Clifford; Powers, Jacquelyn; Stadler, Zsofia; Goldstein, Laura; Kauff, Noah; Khasraw, Mustafa; Offit, Kenneth; Nathanson, Katherine L; Robson, Mark
2013 Apr;119(7):1344-1348, Cancer
— id: 551482, year: 2013, vol: 119, page: 1344, stat: Journal Article,

Hyperactivated mTOR and JAK2/STAT3 pathways: Crucial molecular drivers and potential therapeutic targets of inflammatory breast cancer (IBC)
Jhaveri, K L; Teplinsky, E; Arju, R; Giashuddin, S; Sarfraz, Y; Alexander, M; Darvishian, F; Silvera, D; Levine, P H; Hashmi, S; Hoffman, H J; Singh, B; Goldberg, J D; Hochman, T; Valeta, A; Schneider, R
2013 20 May 2013;31(15):-, Journal of clinical oncology
— id: 451852, year: 2013, vol: 31, page: , stat: Journal Article,

Personalized Medicine and Target Therapy of Breast Cancer
Jhaveri, Komal; Dang, Chau; Hudis, Clifford
Principles of molecular diagnostics and personalized cancer medicine Philadelphia : Wolters Kluwer Health / Lippincott Williams & Wilkins, 2013,
— id: 551582, year: 2013, vol: , page: ?, stat: Chapter,

RAD001-carboplatin combination in triple-negative metastatic breast cancer (TNMBC): A phase II trial
Singh, J C; Stein, S; Volm, M; Smith, J A; Adams, S; Meyers, M; Speyer, J L; Novik, Y; Schneider, R; Formenti, S; Muggia, F; Jhaveri, K L; Goldberg, J D; Heese, S; Li, X; Davis, S; Tiersten, A
2013 20 May 2013;31(15):-, Journal of clinical oncology
— id: 452012, year: 2013, vol: 31, page: , stat: Journal Article,

Fatal hepatitis B reactivation due to everolimus in metastatic breast cancer: case report and review of literature
Teplinsky, Eleonora; Cheung, Derrick; Weisberg, Ilan; Jacobs, Ramon E A; Wolff, Martin; Park, James; Friedman, Kent; Muggia, Franco; Jhaveri, Komal
2013 Sep;141(2):167-172, Breast cancer research & treatment
— id: 551472, year: 2013, vol: 141, page: 167, stat: Journal Article,

Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancer
Ulaner, G A; Eaton, A; Morris, P G; Lilienstein, J; Jhaveri, K; Patil, S; Fazio, M; Larson, S; Hudis, C A; Jochelson, M S
2013 October 2013;2(5):725-733, Cancer medicine
— id: 612542, year: 2013, vol: 2, page: 725, stat: Journal Article,

A Phase I Dose-Escalation Trial of Trastuzumab and Alvespimycin Hydrochloride (KOS-1022; 17 DMAG) in the Treatment of Advanced Solid Tumors
Jhaveri, Komal; Miller, Kathy; Rosen, Lee; Schneider, Bryan; Chap, Linnea; Hannah, Alison; Zhong, Ziyang; Ma, Weining; Hudis, Clifford; Modi, Shanu
2012 Aug;:5090-5098, Clinical cancer research
— id: 174898, year: 2012, vol: , page: 5090, stat: Journal Article,

HSP90 inhibitors for cancer therapy and overcoming drug resistance
Jhaveri, Komal; Modi, Shanu
2012 ;65:471-517, Advances in pharmacology (New York)
— id: 551502, year: 2012, vol: 65, page: 471, stat: Journal Article,

Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers
Jhaveri, Komal; Taldone, Tony; Modi, Shanu; Chiosis, Gabriela
2012 Mar;1823(3):742-755, Biochimica & biophysica acta
— id: 174900, year: 2012, vol: 1823, page: 742, stat: Journal Article,

Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer
Morris, Patrick G; Ulaner, Gary A; Eaton, Anne; Fazio, Maurizio; Jhaveri, Komal; Patil, Sujata; Evangelista, Laura; Park, Joseph Y; Serna-Tamayo, Cristian; Howard, Jane; Larson, Steven; Hudis, Clifford A; McArthur, Heather L; Jochelson, Maxine S
2012 Apr;:5454-5462, Cancer
— id: 174899, year: 2012, vol: , page: 5454, stat: Journal Article,

Breast carcinoma with brain metastases: clinical analysis and immunoprofile on tissue microarrays
Brogi, E; Murphy, C G; Johnson, M L; Conlin, A K; Hsu, M; Patil, S; Akram, M; Nehhozina, T; Jhaveri, K L; Hudis, C A; Seidman, A D
2011 Dec;22(12):2597-2603, Annals of oncology
— id: 551572, year: 2011, vol: 22, page: 2597, stat: Journal Article,

"Prolonged tamoxifen treatment increases relapse-free survival for patients with primary breast cancer expressing high levels of VEGF" Commentary
Jhaveri, Komal; Dickler, M
2011 ;22(2):181-184, Breast diseses : a year book quarterly
— id: 551622, year: 2011, vol: 22, page: 181, stat: Journal Article,

Targeting tumor angiogenesis in combination with endocrine treatment in patients with hormone receptor positive breast cancer
Jhaveri, Komal; Traina, T; Rugo, H; Geneus, S; Patil, S; Hudis, C; Dickler, M
2011 ;3(4):?-?, European journal of clinical & medical oncology
— id: 551632, year: 2011, vol: 3, page: ?, stat: Journal Article,

Erythema nodosum secondary to aromatase inhibitor use in breast cancer patients: case reports and review of the literature
Jhaveri, Komal; Halperin, Peter; Shin, Sandra J; Vahdat, Linda
2007 Dec;106(3):315-318, Breast cancer research & treatment
— id: 174901, year: 2007, vol: 106, page: 315, stat: Journal Article,

Therapy-related myelodysplastic syndrome and acute myeloid leukemia following initial treatment with chemotherapy plus radioimmunotherapy for indolent non-Hodgkin lymphoma
Roboz, Gail J; Bennett, John M; Coleman, Morton; Ritchie, Ellen K; Furman, Richard R; Rossi, Adrianna; Jhaveri, Komal; Feldman, Eric J; Leonard, John P
2007 Aug;31(8):1141-1144, Leukemia research
— id: 174902, year: 2007, vol: 31, page: 1141, stat: Journal Article,

Radioimmunotherapy (RIT) in cancer
Pandit-Taskar, N; Jhaveri, Komal; Divgi, C
2004 ;19(3):53-67, Indian journal of nuclear medicine
— id: 551612, year: 2004, vol: 19, page: 53, stat: Journal Article,